frontotemporal dementia

The relevance of subcortical structures in FTD 1:04
The relevance of subcortical structures in FTD
Martina Bocchetta • 24 Sep 2021
sGFAP: a potential diagnostic and prognostic marker in FTD 2:21
sGFAP: a potential diagnostic and prognostic marker in FTD
Annakaisa Haapasalo • 16 Sep 2021
What’s to come in FTD? Important avenues and key research themes 1:57
What’s to come in FTD? Important avenues and key research themes
Annakaisa Haapasalo • 16 Sep 2021
How does C9orf72 expansion impact protein degradation pathways in FTLD and ALS? 4:02
How does C9orf72 expansion impact protein degradation pathways in FTLD and ALS?
Annakaisa Haapasalo • 16 Sep 2021
A novel genetic marker to detect C9orf72 repeat expansion carriers 3:43
A novel genetic marker to detect C9orf72 repeat expansion carriers
Annakaisa Haapasalo • 16 Sep 2021
Differential early subcortical involvement in genetic FTD 2:48
Differential early subcortical involvement in genetic FTD
Martina Bocchetta • 24 Sep 2021
Imaging biomarkers in frontotemporal dementia: MRI & PET 2:06
Imaging biomarkers in frontotemporal dementia: MRI & PET
Martina Bocchetta • 24 Sep 2021
Emerging biomarkers in FTD: emotional, social cognition & language deficits 2:05
Emerging biomarkers in FTD: emotional, social cognition & language deficits
Adolfo Garcia • 20 Sep 2021
MS research from EAN 2021 2:11
MS research from EAN 2021
Massimo Filippi • 17 Jun 2021
The reconstructed cohort design: tracking rare neurodegenerative diseases 4:40
The reconstructed cohort design: tracking rare neurodegenerative diseases
Giancarlo Logroscino • 22 Oct 2020
The potential of biomarkers in dementia 3:08
The potential of biomarkers in dementia
Giancarlo Logroscino • 22 Oct 2020
ALS and FTD future research 1:51
ALS and FTD future research
Yuliya Shpilyukova • 17 May 2020
ALS and FTD: current treatment landscape 1:40
ALS and FTD: current treatment landscape
Yuliya Shpilyukova • 17 May 2020
C9orf72 hexanucleotide repeat expansion in ALS and FTD 2:31
C9orf72 hexanucleotide repeat expansion in ALS and FTD
Yuliya Shpilyukova • 17 May 2020
The content of VJNeurology is intended for healthcare professionals